GRETCHEN REIBOLD: Open Payments
NPI 1326383423 · FRANKLIN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,775 in 71 payments from 20 companies in 2025. Trend: 2023 $1,905 · 2024 $960 · 2025 $1,775
Food & beverage: $1,575Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $435 |
| SOBI, INC | 4 | $165 |
| Celgene Corporation | 7 | $152 |
| BeOne Medicines USA, Inc. | 6 | $123 |
| PFIZER INC. | 8 | $118 |
| Gilead Sciences, Inc. | 5 | $111 |
| GlaxoSmithKline, LLC. | 4 | $104 |
| Astellas Pharma US Inc | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
Products named: ERLEADA, RYBREVANT, REBLOZYL, Trodelvy, BRUKINSA, TEVIMBRA, NINLARO, Padcev.
Industry payments across NC — which companies pay providers there.
